OM:ORGC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals in Sweden. More Details

Rewards

Trading at 8.8% below our estimate of its fair value

Earnings are forecast to grow 113.86% per year

Risk Analysis

No risks detected for ORGC from our risk checks.


Snowflake Analysis

Exceptional growth potential with adequate balance sheet.

Share Price & News

How has OrganoClick's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ORGC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: ORGC's weekly volatility (7%) has been stable over the past year.


Market Performance


7 Day Return

6.2%

ORGC

3.2%

SE Chemicals

1.6%

SE Market


1 Year Return

84.4%

ORGC

4.7%

SE Chemicals

15.6%

SE Market

Return vs Industry: ORGC exceeded the Swedish Chemicals industry which returned 8.1% over the past year.

Return vs Market: ORGC exceeded the Swedish Market which returned 17.1% over the past year.


Shareholder returns

ORGCIndustryMarket
7 Day6.2%3.2%1.6%
30 Day-7.3%7.4%5.6%
90 Day50.9%8.8%10.9%
1 Year84.4%84.4%7.0%4.7%18.7%15.6%
3 Year65.4%65.4%20.0%11.8%48.6%30.9%
5 Year56.9%56.9%16.7%0.9%87.5%47.6%

Long-Term Price Volatility Vs. Market

How volatile is OrganoClick's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is OrganoClick undervalued compared to its fair value and its price relative to the market?

8.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ORGC (SEK9.96) is trading below our estimate of fair value (SEK10.92)

Significantly Below Fair Value: ORGC is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: ORGC is unprofitable, so we can't compare its PE Ratio to the SE Chemicals industry average.

PE vs Market: ORGC is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ORGC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ORGC is overvalued based on its PB Ratio (14.4x) compared to the SE Chemicals industry average (7.9x).


Next Steps

Future Growth

How is OrganoClick forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

113.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORGC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).

Earnings vs Market: ORGC is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ORGC's is expected to become profitable in the next 3 years.

Revenue vs Market: ORGC's revenue (40% per year) is forecast to grow faster than the Swedish market (3.4% per year).

High Growth Revenue: ORGC's revenue (40% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORGC's Return on Equity is forecast to be high in 3 years time (34.1%)


Next Steps

Past Performance

How has OrganoClick performed over the past 5 years?

2.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORGC is currently unprofitable.

Growing Profit Margin: ORGC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ORGC is unprofitable, but has reduced losses over the past 5 years at a rate of 2.8% per year.

Accelerating Growth: Unable to compare ORGC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ORGC is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-12%).


Return on Equity

High ROE: ORGC has a negative Return on Equity (-20.53%), as it is currently unprofitable.


Next Steps

Financial Health

How is OrganoClick's financial position?


Financial Position Analysis

Short Term Liabilities: ORGC's short term assets (SEK69.3M) exceed its short term liabilities (SEK43.5M).

Long Term Liabilities: ORGC's short term assets (SEK69.3M) exceed its long term liabilities (SEK24.6M).


Debt to Equity History and Analysis

Debt Level: ORGC's debt to equity ratio (17.9%) is considered satisfactory.

Reducing Debt: ORGC's debt to equity ratio has increased from 12.8% to 17.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ORGC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ORGC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is OrganoClick current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ORGC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ORGC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ORGC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ORGC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ORGC's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.0yrs

Average management tenure


CEO

Marten Hellberg (40 yo)

15yrs

Tenure

kr1,394,000

Compensation

Mr. Marten Hellberg serves as Director at Svenska Aerogel Holding AB (publ) since June 11, 2018. He Co-founded OrganoClick AB in 2006 and has been its Chief Executive Officer since 2006 and has been its Pr...


CEO Compensation Analysis

Compensation vs Market: Marten's total compensation ($USD168.15K) is below average for companies of similar size in the Swedish market ($USD241.80K).

Compensation vs Earnings: Marten's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Marten Hellberg
Co-Founder15yrskr1.39m8.01%
SEK 73.8m
Jessica Sundborg
Chief Financial Officer8yrsno data0.16%
SEK 1.5m
Mikael Wickström
Chief Operating Officer2.67yrsno data0.0011%
SEK 10.0k
Maria Wennman
Research & Development Directorno datano data0.016%
SEK 147.4k

8.0yrs

Average Tenure

Experienced Management: ORGC's management team is seasoned and experienced (8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jan Johansson
Chairman5yrskr400.00k0.18%
SEK 1.7m
Hakan Gustavson
Director4.33yrskr100.00kno data
Charlotte Jansdotter Karlberg
Director0.67yrno datano data
Claes-Goran Beckeman
Director13yrskr100.00k0.75%
SEK 6.9m
Malin Bugge
Director0.67yrno datano data

4.3yrs

Average Tenure

62yo

Average Age

Experienced Board: ORGC's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ORGC insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

OrganoClick AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: OrganoClick AB (publ)
  • Ticker: ORGC
  • Exchange: OM
  • Founded: 2006
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: kr921.128m
  • Shares outstanding: 92.11m
  • Website: https://www.organoclick.com

Number of Employees


Location

  • OrganoClick AB (publ)
  • Linjalvägen 9
  • Täby
  • Stockholm County
  • 187 66
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ORGCOM (OMX Nordic Exchange Stockholm)YesCommon SharesSESEKFeb 2015
0CFDB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2015

Biography

OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals in Sweden. It offers OrganoWood, a wooden material that is resistant t...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/22 20:30
End of Day Share Price2021/01/22 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.